BeStock  

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #452Infectious DiseaseCannabis & Hemp
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings91.2x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -6.6x

#2813 of 2996 stocks by PE (1 = cheapest)

Price / book5.7x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 2.6x

#4638 of 5338 stocks by PB (1 = cheapest)

Price / sales2.7x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 1.2x

#3107 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-152x-62x28x117xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$45.00
Price vs. fair value-12.8%Trading below the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.74 – 2.63 96% (pricier than usual) #4638 of 5338 (1 = cheapest)
PE 91.23 25.53 -6.64 99% (pricier than usual) #2813 of 2996 (1 = cheapest)
PS 2.66 2.68 1.18 97% (pricier than usual) #3107 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TEVA.

Sign in to join the discussion.

Scroll to Top